AAV-delivered Gene Therapies
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
9
NCT07058662
A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of BBM-D101 in the Treatment of Duchenne Muscular Dystrophy.
Phase: Phase 1/2
Role: Collaborator
Start: Jul 31, 2025
Completion: Jun 30, 2031
Loading map...